A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Sponsors and Collaborators
Kissei Pharmaceutical Co., Ltd.

Contact
Kissei Pharmaceutical Co., Ltd
[email protected]

ClinicalTrials.gov Identifier
NCT01850602


Continue Reading